Sarepta Therapeutics, headquartered in Cambridge, Massachusetts, is a commercial-stage biopharmaceutical company focused on the discovery and development of unique RNA-targeted therapeutics for the treatment of rare neuromuscular diseases. The Company is primarily focused on rapidly advancing the development of its potentially disease-modifying DMD drug candidates. For more information, please visit us at www.sarepta.com.
- Company Name:Sarepta Therapeutics
(View Trends)
-
Headquarters: (View Map)Cambridge, MA, United States
-
500 - 1,000 employees
- 664247 Global Rank
- 331944 United States
- 110 K Estimated Visits
-
Search55.01%
-
Direct29.19%
-
Social6.85%
-
Referrals6.78%
-
Mail2.16%
-
Display0.00%
-
62.72%
-
5.35%
-
4.78%
-
3.33%
- United States 77.9%
- India 6.1%
- Chinese Traditional
- 50 Downloads
- 10 SDKs
- 0 Total reviews
- App Url: https://play.google.com/store/apps/details?id=com.divisionof.exonapp
- App Support: http://Exonmapexplorer.com
- Genre: tools
- Bundle ID: com.divisionof.exonapp
- App Size: 9.81 M
- Release Date: February 11th, 2019
- Update Date: February 11th, 2019
Description:
Knowing the DMD gene mutation is not enough. An additional step is required to understand exon skipping. To explore exon skipping the information supplied from a genetic test may be applied to the map of the dystrophin gene. If skipping an exon next to the missing sequence will restore the reading frame, the mutation may be considered amenable to exon skipping. In rare cases restoration of the reading frame may result in a stop codon.
This App is for educational purposes and is not intended or validated as a diagnostic tool.
Features:
- Exon Map Explorer
- Exon Map Explorer Tutorial
- Reviewing DMD Genetic Reports
- Genetic Testing Resources
-
Standard0%
They are headquartered at Cambridge, MA, United States, and have 4 advertising & marketing contacts listed on Kochava. Sarepta Therapeutics works with Advertising technology companies such as DoubleClick.Net, Facebook Custom Audiences, Microsoft Advertising, FLoC Opt-Out, FLoC, Google Floodlight Counter.